Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam (Yinuosi) in Lennox-Gastaut syndrome
CTR20241279Phase 4Terminated
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clobazam in Lennox-Gastaut syndrome (LGS), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Apr 2024; status: terminated.
02
Drugs
clobazam
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on CTR20241279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241279.